We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $3.63B
1-Year Est. Return 30.51%
This Fund
S&P 500
This Quarter Est. Return
-4.61%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
AUM
$979M
AUM Growth
+$141M
Cap. Flow
+$200M
Cap. Flow %
20.42%
Top 10 Hldgs %
51.65%
Holding
173
New
54
Increased
7
Reduced
11
Closed
58

Top Buys

Rank Stock Value
1
ROL icon
Rollins
ROL
+$101M
2
ARM icon
Arm
ARM
+$66.4M
3
ENB icon
Enbridge
ENB
+$63M
4
AER icon
AerCap
AER
+$46.2M
5
CG icon
Carlyle Group
CG
+$20.9M

Top Sells

Rank Stock Value
1
RNR icon
RenaissanceRe
RNR
+$19.2M
2
AGL icon
Agilon Health
AGL
+$17.3M
3
EG icon
Everest Group
EG
+$17.1M
4
COR icon
Cencora
COR
+$16.4M
5
CCC
CCC Intelligent Solutions
CCC
+$15.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.51%
2 Technology 18.14%
3 Energy 14.52%
4 Industrials 14.19%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWX icon
76
Southwest Gas
SWX
$6.56B
$1.51M 0.15%
25,000
TRNO icon
77
Terreno Realty
TRNO
$7.45B
$1.42M 0.15%
25,000
BE icon
78
Bloom Energy
BE
$62B
$1.33M 0.14%
100,000
WHD icon
79
Cactus
WHD
$5.7B
$1.26M 0.13%
25,000
AMKR icon
80
Amkor Technology
AMKR
$13.1B
$1.22M 0.12%
+53,837
New +$1.42M
KVYO icon
81
Klaviyo
KVYO
$5.09B
$1.21M 0.12%
+35,000
New +$1.2M
GSHD icon
82
Goosehead Insurance
GSHD
$2.29B
$1.14M 0.12%
+15,300
New +$1.03M
REZI icon
83
Resideo Technologies
REZI
$3.67B
$1.03M 0.1%
+64,900
New +$1.09M
IDYA icon
84
IDEAYA Biosciences
IDYA
$3.54B
$1.01M 0.1%
37,500
VSEC icon
85
VSE Corp
VSEC
$6.21B
$1.01M 0.1%
+20,000
New +$1.09M
BCYC
86
Bicycle Therapeutics
BCYC
$288M
$1M 0.1%
+50,000
New +$1.14M
ATAT icon
87
Atour Lifestyle Holdings
ATAT
$4.85B
$943K 0.1%
50,000
TARS icon
88
Tarsus Pharmaceuticals
TARS
$2.97B
$889K 0.09%
+50,000
New +$885K
NVTS icon
89
Navitas Semiconductor
NVTS
$3.44B
$869K 0.09%
125,000
-125,000
-50% -$1.11M
HPK icon
90
HighPeak Energy
HPK
$1B
$844K 0.09%
+50,000
New +$726K
PTGX icon
91
Protagonist Therapeutics
PTGX
$9.71B
$834K 0.09%
50,000
KRUS icon
92
Kura Sushi USA
KRUS
$590M
$827K 0.08%
12,500
GRNT icon
93
Granite Ridge Resources
GRNT
$670M
$809K 0.08%
+132,575
New +$926K
SBH icon
94
Sally Beauty Holdings
SBH
$1.57B
$787K 0.08%
+93,972
New +$998K
SLRN
95
DELISTED
ACELYRIN
SLRN
$712K 0.07%
70,000
RVMD icon
96
Revolution Medicines
RVMD
$44.4B
$692K 0.07%
25,000
EXFY icon
97
Expensify
EXFY
$225M
$577K 0.06%
+177,467
New +$959K
EPRT icon
98
Essential Properties Realty Trust
EPRT
$6.53B
$541K 0.06%
25,000
+15,000
+150% +$358K
SGMT icon
99
Sagimet Biosciences
SGMT
$591M
$528K 0.05%
+60,000
New +$799K
RYZB
100
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$444K 0.05%
+20,000
New +$420K

Similar funds

Ghisallo Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Ghisallo Capital Management held 173 positions worth $979M, up 17% from $838M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Ghisallo Capital Management deployed $200M of net new capital in Q3 2023, opening 54 new positions and adding to 7 existing holdings. Its largest new stake was Rollins: 2,500,000 shares worth $93.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 15% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was RenaissanceRe, an estimated $19.2M trimmed.

  • Ghisallo Capital Management's largest Q3 2023 buy was Rollins: 2,500,000 shares worth $93.3M.
  • Ghisallo Capital Management added most to AerCap in Q3 2023, an estimated $46.2M increase.
  • Ghisallo Capital Management's biggest Q3 2023 reduction was RenaissanceRe, cutting an estimated $19.2M.
  • Ghisallo Capital Management fully exited Agilon Health in Q3 2023, selling an estimated $17.3M.
  • Ghisallo Capital Management's ten largest holdings make up 52% of its $979M portfolio in Q3 2023.
  • Ghisallo Capital Management opened 54 new positions and closed 58 in Q3 2023.
  • Ghisallo Capital Management's portfolio value rose 17% quarter-over-quarter to $979M.

Based on Ghisallo Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.